MXPA02012529A - Extractos de especies de sophora, procedimiento para su preparacion y su uso. - Google Patents

Extractos de especies de sophora, procedimiento para su preparacion y su uso.

Info

Publication number
MXPA02012529A
MXPA02012529A MXPA02012529A MXPA02012529A MXPA02012529A MX PA02012529 A MXPA02012529 A MX PA02012529A MX PA02012529 A MXPA02012529 A MX PA02012529A MX PA02012529 A MXPA02012529 A MX PA02012529A MX PA02012529 A MXPA02012529 A MX PA02012529A
Authority
MX
Mexico
Prior art keywords
extracts
sophora
prophylaxis
therapy
producing
Prior art date
Application number
MXPA02012529A
Other languages
English (en)
Inventor
Clemens Erdelmeier
Original Assignee
Schwabe Willmar Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwabe Willmar Gmbh & Co filed Critical Schwabe Willmar Gmbh & Co
Publication of MXPA02012529A publication Critical patent/MXPA02012529A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)

Abstract

La presente invencion se refiere a extractos de especies de Sophora, a un metodo para su produccion y su uso para la profilaxis y la terapia de estados patologicos, que son provocados por la falta de estrogenos o otra falta de regulacion hormonal.
MXPA02012529A 2000-06-29 2001-06-29 Extractos de especies de sophora, procedimiento para su preparacion y su uso. MXPA02012529A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031651A DE10031651A1 (de) 2000-06-29 2000-06-29 Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung
PCT/DE2001/002460 WO2002000236A1 (de) 2000-06-29 2001-06-29 Extrakte aus sophora-arten, verfahren zu ihrer herstellung und verwendung

Publications (1)

Publication Number Publication Date
MXPA02012529A true MXPA02012529A (es) 2004-05-05

Family

ID=7647187

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012529A MXPA02012529A (es) 2000-06-29 2001-06-29 Extractos de especies de sophora, procedimiento para su preparacion y su uso.

Country Status (10)

Country Link
US (1) US7381429B2 (es)
EP (1) EP1294388B1 (es)
JP (1) JP4393062B2 (es)
CN (1) CN1299672C (es)
AT (1) ATE257388T1 (es)
AU (1) AU2001275659A1 (es)
DE (2) DE10031651A1 (es)
ES (1) ES2213705T3 (es)
MX (1) MXPA02012529A (es)
WO (1) WO2002000236A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099725A1 (en) * 2001-02-26 2003-05-29 Global Cancer Strategies Ltd. Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
KR100449887B1 (ko) * 2003-10-31 2004-09-22 주식회사 렉스진바이오텍 이소플라본을 함유하는 괴각 추출물의 제조방법
KR100509682B1 (ko) * 2003-11-26 2005-08-23 주식회사 렉스진바이오텍 괴각 추출물을 유효성분으로 함유하는 골 대사성 질환의 예방 및 치료용 약학적 조성물
CN100528855C (zh) * 2005-12-27 2009-08-19 中国科学院山西煤炭化学研究所 由苦参生产苦参总黄酮或黄酮盐的方法
CN100528856C (zh) * 2005-12-27 2009-08-19 中国科学院山西煤炭化学研究所 一种生产苦参总黄酮及黄酮盐类的方法
EP2035430A1 (en) * 2006-05-03 2009-03-18 Symrise GmbH & Co. KG 6h-benzofuro[3,2-c][1]benzopyran and [2]benzopyrano [4,3-b][1]benzopyran derivatives and wood extracts of these compounds as aryl hydrocarbon receptor (ahr) antagonists for the prevention of uv-b induced skin damage
WO2008051586A2 (en) 2006-10-24 2008-05-02 Krempin David W Anti-resorptive and bone building dietary supplements and methods of use
CN101474239B (zh) * 2009-01-21 2013-11-27 沈阳药科大学 朝鲜槐提取物及其提取方法和用途
CN101507750B (zh) * 2009-04-01 2012-10-03 大连医科大学 苦参总黄酮在制备药物中的应用
US7897184B1 (en) 2009-08-13 2011-03-01 Access Business Group International Llc Topical composition with skin lightening effect
KR20110097462A (ko) * 2010-02-25 2011-08-31 한국 한의학 연구원 산두근 추출물을 유효성분으로 함유하는 아토피 예방 또는 치료용 조성물 및 이의 제조방법
CN103006761B (zh) * 2012-12-06 2015-02-18 江苏大学 一种山豆根抗肿瘤有效组分提取物及其制法和用途
CN103083392B (zh) * 2012-12-27 2015-10-07 浙江工业大学 一种分离富集山豆根中具异戊烯基黄酮部位的方法
JP6393680B2 (ja) 2013-05-23 2018-09-19 学校法人近畿大学 Ｔ型カルシウムチャネル阻害剤
US20190231835A1 (en) * 2016-08-25 2019-08-01 University-Industry Cooperation Group Of Kyung Hee University Pharmaceutical composition containing sophora japonica l. extract as active ingredient for the prevention and treatment of neurodegenerative disorders
CN106749309A (zh) * 2016-12-31 2017-05-31 南宁馨艺荣生物科技有限公司 一种从山豆根中提取纯化高丽槐素的方法
WO2019065532A1 (ja) 2017-09-28 2019-04-04 学校法人近畿大学 Ｔ型カルシウムチャネル阻害剤
WO2019208595A1 (ja) * 2018-04-25 2019-10-31 オリザ油化株式会社 エストロゲン活性調整剤およびそれを用いた不定愁訴改善剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1697819A1 (ru) 1984-04-26 1991-12-15 В.М.Пойченко и В.А.Борисенко Способ лечени хронического простатита
JPH0273079A (ja) * 1988-09-09 1990-03-13 Daicel Chem Ind Ltd フラボノイドの製法
CN1099259A (zh) * 1993-08-27 1995-03-01 阿坝藏族羌族自治州医药公司 化妆梳洗用品的保健护肤添加剂
JP3327699B2 (ja) * 1994-08-31 2002-09-24 一丸ファルコス株式会社 クジン抽出物含有抗菌・防腐剤及び化粧料
CN1053829C (zh) 1995-12-13 2000-06-28 韩贵民 一种治疗妇科病的中药制备方法
CN1060665C (zh) 1996-05-10 2001-01-17 潘兴光 一种治疗心脏病的药物
JPH1017460A (ja) * 1996-06-28 1998-01-20 Shiseido Co Ltd 抗老化剤
JPH1017461A (ja) * 1996-06-28 1998-01-20 Shiseido Co Ltd 肌荒れ改善用外用剤
CN1095362C (zh) * 1996-09-26 2002-12-04 内蒙古苦参生化集团有限责任公司 一种含有苦豆子总生物碱的洗浴液
JPH1135454A (ja) * 1997-07-22 1999-02-09 Meiji Milk Prod Co Ltd 抗腫瘍剤
WO1999007154A1 (en) * 1997-07-28 1999-02-11 Idt International Digital Technologies Deutschland Gmbh Method and apparatus for compression of video images and image residuals
CN1175458A (zh) 1997-09-05 1998-03-11 张玉杰 治疗心脑血管疾病的中药

Also Published As

Publication number Publication date
DE50101304D1 (de) 2004-02-12
ATE257388T1 (de) 2004-01-15
CN1299672C (zh) 2007-02-14
EP1294388B1 (de) 2004-01-07
US20030180394A1 (en) 2003-09-25
DE10031651A1 (de) 2002-01-17
CN1633301A (zh) 2005-06-29
AU2001275659A1 (en) 2002-01-08
ES2213705T3 (es) 2004-09-01
US7381429B2 (en) 2008-06-03
EP1294388A1 (de) 2003-03-26
JP2004501201A (ja) 2004-01-15
WO2002000236A1 (de) 2002-01-03
JP4393062B2 (ja) 2010-01-06

Similar Documents

Publication Publication Date Title
MXPA02012529A (es) Extractos de especies de sophora, procedimiento para su preparacion y su uso.
MXPA02012528A (es) Uso terapeutico de extractos de sophora flavescens o sophora subprostata.
AU2003299585A8 (en) Water-soluble products and methods of making and using the same
GB2380775A (en) Gearbox
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
MXPA02004666A (es) Gelatinas recombinantes.
YU5003A (sh) Nova farmaceutska smeša
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
AU2001293202A1 (en) Process for extracting compounds from plants
MXPA03003982A (es) Metodos para regular la produccion de gaba en plantas.
MXPA03010322A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE POLIISOCIANATOS.
EP1421850A4 (en) COMPOSITIONS THAT ACTIVATE PLANT RESISTANCE TO DISEASES AND A PROCESS FOR PRODUCING THE SAME
WO2004031402A3 (en) Methylation profile of cancer
MXPA02012644A (es) Metodo de planeacion de produccion y sistema para planeacion de produccion.
WO2003050137A3 (en) Toll-like receptor 4 mutations
GB0121421D0 (en) Method and system for making production plan
EP1420440A4 (en) PITAXIAL TRENCH AND PRODUCTION PROCESS
AU2002336310A1 (en) Method for producing metallic iron
CA97011S (en) Control lever for earth moving machines
WO2002028432A3 (en) Stem cell-based methods for preventing and treating tumor
AU2002226308A1 (en) Method for producing dnda
AU2003222462A1 (en) Method of performing soojichim acupuncture using bodycopy
WO2003106058A3 (en) EXTRACTION METHODS AND APPARATUS

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status